Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 5, 1997, Pages 466-472

  Gentile, Deborah A ^a   Henry, Jean ^a   Katz, Alan J ^a   Skoner, David P ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIAC GLYCOSIDE; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DIGOXIN; INTERLEUKIN 2; OUABAIN; PHYTOHEMAGGLUTININ;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030947440     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63233-4     Document Type: Article

References (28)

1. + adenosine triphosphatase (ATPase) enzyme in allergy. J Allergy Clin Immunol 1991;87:476-82.
2. Souhrada M, Blaustein MP, Hamlyn JM. Sodium transport inhibition, cell calcium and hypertension: the natriuretic hormone/Na-Ca exchange/hypertension hypothesis. Am J Med 1984;77(4A):45-59.
3. Poston L, Morris JF, Wolfe CD, Hilton PJ. Serum digoxin-like substances in pregnancy-induced hypertension. Clin Sci 1989;77:189-94.
4. Titus E, Weiss H, Hojdu S. Isolation of a cardiac-active principle from mammalian tissues. Science 1956;124: 1205-6.
5. Hamlyn JM, Blaustein MP, Bora S, et al. Identification and characterization of a ouabain-like compound from human plasma. Pro Natl Assoc Sci USA 1991;8:6259-63.
6. + ATPase. Biochem Biophys Res Comm 1980;94:240-7.
7. Erjavec F, Fergan I. Changes in histamine secretion from mast cells caused by digitalis glycosides. Agents Actions 1990;30:125-7.
8. Nayler RA, Mitchell HW. Airways hyperreactivity and bronchoconstriction induced by vanadate in the guinea-pig. Br J Pharmacol 1987;92:173-80.
9. Quastel MR, Kaplan JG. Lymphocyte stimulation: the effect of ouabain on nucleic acid and protein synthesis. Exptl Cell Res 1970;62:407-20.
10. + B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol 1990;20: 201-6.
11. + T cells inhibit HIV replication in naturally infected T Cells. Evidence for a soluble inhibitor. J Immunol 1990;144:2961-6.
12. + T cells. J Immunol Meth 1986;90:179-87.
13. + T cells. J Virol Meth 1989;25:293-300.
14. Coligan JE, Kruisbeek AM, Margulies DH, et al. Trypan blue exclusion test of cell viability. In: Current Protocols in Immunology. New York: John Wiley and Sons, 1991:A.3.3.
15. Wright P, Quastel MR, Kaplan JG. Differential sensitivity of antigen and mitogen stimulated human leukocytes to prolonged inhibition of potassium transport. Exp Cell Res 1973;79: 87-94.
16. Tormey DC, Fundenberg HH, Kamin RM. Effect of prednisolone on synthesis of DNA and RNA by Human lymphocytes in vitro. Nature 1967;213: 281-2.
17. Gin W, Kay AB. The effect of corticosteroid in monocyte and neutrophil activation in bronchial asthma. J Allergy Clin Immunol 1985;76:675-82.
18. Pene I, Rousset F, Brieve F, et al. IgE production by normal human lymphocytes induced by interleukin-4 and suppressed by interferons T and E and prostaglandin E. Proc Natl Acad Sci USA 1988;85:6880-4.
19. Elves MW, Cough J, Israels MCG. The place of the lymphocyte in the reticuloendothelial system: a study of the in vitro effect of prednisolone on lymphocytes. Acta Haematol 1964;32: 100-5.
20. Prasad KVS, Severini A, Kaplan JG. Sodium ion influx in proliferating lymphocytes: an early component of the mitogenic signal. Arch Biochem Biophys 1987;252:515-27.
21. Metzger H, Alcaraz G, Hohman R, et al. The receptor with high affinity for immunoglobulin E. Ann Rev Immunol 1986;4:419-70.
22. Oliver JM, Seagrave JC, Stump RF, et al. Signal transduction and cellular response in RBL-2H3 mast cells. Prog Allergy 1988;42:185-245.
23. Johnson AR, Erdos EG. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 1973;142:1252-6.
24. Bellini T, Degani D, Matteuzzi M, Dallocchio F. Effect of 17 B-estradiol on calcium response to phytohaemagglutinin in human lymphocytes. Bioscience Reports 1990;10:73-8.
25. Dornand J, Favero J, Bonnafous J, Mani C. Mechanism whereby ouabain inhibits T lymphocyte activation. Immunobiol 1986;171:436-50.
26. Härtel G, Kyllönen K, Merikallio E. Human serum and myocardium digoxin. Clin Pharmacol Ther 1976; 19:153-7.
27. Reuning RH, Geraets DR, Rocci Jr, ML, Vlasses PH. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. In: KodaKimble MA, Young LY, eds. Applied therapeutics, Fifth Edition. Washington: Vancouver, 1992: 161-252.
28. Coltart J, Howard M, Chamberlain D. Myocardial and skeletal muscle concentration of digoxin in patients on long-term therapy. Br Med J 1972;2: 318-9.